Short call | Trump's tariff tantrums can dial up inflation woes overseas; Dixon Tech, Apollo Hospitals in focus

Short Call

Donald Trump’s stunning encore at the White House has set the world stage abuzz, but it’s his trademark tariff tantrums that are stealing the spotlight. Everyone’s holding their breath, popcorn in hand, waiting to see what dramatic move he’ll make to champion his America First crusade.

True to form, Trump’s approach to federal revenue involves less taxing Americans and more “passing the buck” to other nations - especially China. His planned tariffs could be hefty enough to send shockwaves abroad, hiking up export prices to the US and potentially fueling inflation overseas. It’s hardly a party for anyone, particularly with the US dollar index flexing its muscles at a two-year high, between 108 and 109.

Closer to home, Aishvarya Dadheech, founder and CIO of Fident Asset Management, warns that India might be in for a bumpy ride. “Not only could these tariffs crank up inflation, but they’d also throw a wrench into the Reserve Bank of India’s plans for deeper rate cuts,” he told Moneycontrol.

Nomura analysts predict that while China might face tariffs as steep as 60 percent, the ripple effect could extend across Asia and Europe, putting their economies in the line of fire too. The tariffs, which are a tax on goods that are imported, could hurt their sales to the US, which otherwise was aimed to boost their economies.

Follow our live blog for all the market action

Apollo Hospitals (Rs 6,919.15, +2%)

Top Nifty gainer after KIE’s upgrade to ‘buy’

Bull Case: Despite 70% of total bed expansion being greenfield, the company’s bed expansion plan still remains significantly lower than that of most peers. This positions the company well for fewer execution risks, KIE wrote. Reduced Apollo 24/7 losses, stronger competitive position, diversified presence and limited exposure to hypercompetitive micro-markets provides scope for strong upside.

Bear Case: Continued losses from Apollo 24/7 may hamper the company’s earnings growth. Pending exact clarity on timelines and detailed financials, of the Apollo HealthCo-Keimed merger may add a level of uncertainty for the stock.

Dixon Technologies (Rs 15,132, -13.7%)

Shares fell after the company reported a sequential decline in its consolidated net profit and revenue from operations for the quarter ending December.

Bull Case: Delivered robust performance in its mobile and EMS segments. Company's next growth phase is anticipated to stem from its strong focus on backward integration, starting with its entry into display, camera, and battery module assembly, followed by plans to establish a display fabrication unit.

Bear Case: Higher-than-estimated depreciation and finance cost led to a miss on PAT. Motilal Oswal Financial Services flagged potential risks, including slower-than-expected market growth, loss of key client relationships, increased competition, and limited bargaining power with clients.

(With inputs from Vaibhavi and Neeshita)